Aurora Cannabis rejects Curaleaf bid, defends at-the-market share program

Reuters2026/09/14 18:12

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

Aurora Cannabis rejected Curaleaf’s bid as inadequate, urging shareholders to take no action and not tender shares.
The response challenged Curaleaf’s move to halt Aurora’s at-the-market program, calling it a distraction from valuation.
Aurora said the ATM was disclosed in February 2026, predates the bid, has been inactive for weeks, and was unused for three years.
The company highlighted Curaleaf’s balance sheet, citing more than $1 billion of debt, including $500 million at 11.5%.
Aurora said it raised a complaint with the Alberta Securities Commission on Sept. 2 over alleged regulatory deficiencies in the bid.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Aurora Cannabis Inc. published the original content used to generate this news brief via CNW (Ref. ID: 202609141412CANADANWCANADAPR_C4779) on September 14, 2026, and is solely responsible for the information contained therein.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Aurora Cannabis rejects Curaleaf bid, defends at-the-market share program

You may also like

Crypto prices